Recurrent Marginal Zone Lymphoma
Oncology·MeSH: Lymphoma, B-Cell, Marginal Zone
Prevalence
56.0 / 100K
Incidence
19.6 / 100K/yr
0 drugs in development·0 companies·3 clinical trials
Frequently asked questions
How many clinical trials target Recurrent Marginal Zone Lymphoma?
There are 3 clinical trials targeting Recurrent Marginal Zone Lymphoma tracked by BioSniper.
What is the prevalence of Recurrent Marginal Zone Lymphoma?
The estimated prevalence of Recurrent Marginal Zone Lymphoma is approximately 56.0 per 100,000 population.
Deep-dive into Recurrent Marginal Zone Lymphoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis